Search Results

There are 13327 results for: content related to: Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma

  1. Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update

    Hepatology Research

    Volume 42, Issue 6, June 2012, Pages: 523–542, Shuichi Kaneko, Junji Furuse, Masatoshi Kudo, Kenji Ikeda, Masao Honda, Yasunari Nakamoto, Morikazu Onchi, Goshi Shiota, Osamu Yokosuka, Isao Sakaida, Tetsuo Takehara, Yoshiyuki Ueno, Kazumasa Hiroishi, Shuhei Nishiguchi, Hisataka Moriwaki, Kazuhide Yamamoto, Michio Sata, Shuntaro Obi, Shiro Miyayama and Yukinori Imai

    Version of Record online : 8 MAY 2012, DOI: 10.1111/j.1872-034X.2012.00981.x

  2. You have free access to this content
    Poster Session 1: Cellular Immunobiology, Preservation, and Cell Transplantation in Transplant; Clinical: Hepatocellular Carcinoma and Cholangiocarcinoma

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 380A–456A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28212

  3. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  4. Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy: A Korean multicenter study

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 7, July 2014, Pages: 1463–1469, Sangheun Lee, Beom Kyung Kim, Seung Up Kim, Soo Young Park, Ja Kyung Kim, Hyun Woong Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Won Young Tak, Young Oh Kweon, Jung Il Lee, Kwan Sik Lee, Hyung Joon Kim and Kwang-Hyub Han

    Version of Record online : 15 JUL 2014, DOI: 10.1111/jgh.12542

  5. Chemoembolization outcomes for hepatocellular carcinoma in cirrhotic patients with compromised liver function

    HPB

    Volume 16, Issue 7, July 2014, Pages: 648–655, David P. Dorn, Mary K. Bryant, Jessica Zarzour, J. Kevin Smith, David T. Redden, Souheil Saddekni, Ahmed Kamel Abdel Aal, Stephen Gray, Jared White, Devin E. Eckhoff and Derek A. DuBay

    Version of Record online : 20 NOV 2013, DOI: 10.1111/hpb.12194

  6. Effect of treatment with branched-chain amino acids during sorafenib therapy for unresectable hepatocellular carcinoma

    Hepatology Research

    Volume 44, Issue 3, March 2014, Pages: 302–312, Haruhiko Takeda, Hiroki Nishikawa, Eriko Iguchi, Yoshiaki Ohara, Azusa Sakamoto, Sumio Saito, Norihiro Nishijima, Akihiro Nasu, Hideyuki Komekado, Ryuichi Kita, Toru Kimura and Yukio Osaki

    Version of Record online : 29 APR 2013, DOI: 10.1111/hepr.12125

  7. Abstract Index

    Journal of Gastroenterology and Hepatology

    Volume 19, Issue s7, December 2004, Pages: A676–A868,

    Version of Record online : 3 DEC 2004, DOI: 10.1111/j.1440-1746.2004.03735.x

  8. You have free access to this content
    Liver Cancer

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1213A–1276A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26883

  9. Quantitative evaluation of liver cirrhosis using T1 relaxation time with 3 tesla MRI before and after oxygen inhalation

    Journal of Magnetic Resonance Imaging

    Volume 36, Issue 2, August 2012, Pages: 405–410, Kyung Ah Kim, Mi-Suk Park, In-Seong Kim, Berthold Kiefer, Woo-Suk Chung, Myeong-Jin Kim and Ki Whang Kim

    Version of Record online : 5 MAR 2012, DOI: 10.1002/jmri.23620

  10. Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies

    Liver International

    Volume 29, Issue 4, April 2009, Pages: 502–510, Puneeta Tandon and Guadalupe Garcia-Tsao

    Version of Record online : 6 JAN 2009, DOI: 10.1111/j.1478-3231.2008.01957.x

  11. You have free access to this content
    The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis

    Cancer

    Volume 118, Issue 21, 1 November 2012, Pages: 5293–5301, Joanne Chiu, Yuen Fong Tang, Tzy-Jyun Yao, Ashley Wong, Hilda Wong, Roland Leung, Pierre Chan, Tan To Cheung, Albert C. Chan, Roberta Pang, Sheung-Tat Fan, Ronnie Poon and Thomas Yau

    Version of Record online : 19 APR 2012, DOI: 10.1002/cncr.27543

  12. Post-progression survival and progression-free survival in patients with advanced hepatocellular carcinoma treated by sorafenib

    Hepatology Research

    Volume 46, Issue 7, June 2016, Pages: 650–656, Takeshi Terashima, Tatsuya Yamashita, Noboru Takata, Hidetoshi Nakagawa, Tadashi Toyama, Kuniaki Arai, Kazuya Kitamura, Taro Yamashita, Yoshio Sakai, Eishiro Mizukoshi, Masao Honda and Shuichi Kaneko

    Version of Record online : 2 NOV 2015, DOI: 10.1111/hepr.12601

  13. Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus-endemic area

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 4, April 2014, Pages: 820–829, Hee-Won Kwak, Joong-Won Park, Byung-Ho Nam, Ami Yu, Sang Myung Woo, Tae Hyun Kim, Seong Hoon Kim, Young Hwan Koh, Hyun Beom Kim, Sang Jae Park, Woo Jin Lee, Eun Kyung Hong and Chang-Min Kim

    Version of Record online : 20 MAR 2014, DOI: 10.1111/jgh.12470

  14. You have free access to this content
    The International Liver Transplantation Society: 16th Annual International Congress

    Liver Transplantation

    Volume 16, Issue S1, June 2010, Pages: S1–S284,

    Version of Record online : 25 MAY 2010, DOI: 10.1002/lt.22086

  15. You have free access to this content
    Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child-Pugh score

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 10, November 2011, Pages: 1193–1201, A. Hollebecque, S. Cattan, O. Romano, G. Sergent, A. Mourad, A. Louvet, S. Dharancy, E. Boleslawski, S. Truant, F.-R. Pruvot, M. Hebbar, O. Ernst and P. Mathurin

    Version of Record online : 29 SEP 2011, DOI: 10.1111/j.1365-2036.2011.04860.x

  16. APASL Abstracts, Bali 2005

    Liver International

    Volume 25, Issue 6, December 2005, Pages: 1270–1384,

    Version of Record online : 11 NOV 2005, DOI: 10.1111/j.1478-3231.2005.01182.x

  17. Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma

    Journal of Digestive Diseases

    Volume 16, Issue 9, September 2015, Pages: 505–512, Tomokazu Kawaoka, Hiroshi Aikata, Hideyuki Hyogo, Reona Morio, Kei Morio, Masahiro Hatooka, Takayuki Fukuhara, Tomoki Kobayashi, Noriaki Naeshiro, Daisuke Miyaki, Akira Hiramatsu, Michio Imamura, Yoshiiku Kawakami, Shoichi Takahashi, Koji Waki, Keiji Tsuji, Hirotaka Kohno, Hiroshi Kohno, Takashi Moriya and Kazuaki Chayama

    Version of Record online : 28 SEP 2015, DOI: 10.1111/1751-2980.12267

  18. Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma

    Liver International

    Volume 34, Issue 2, February 2014, Pages: 313–321, Hana Park, Seung Up Kim, Jun Young Park, Do Young Kim, Sang Hoon Ahn, Chae Yoon Chon, Kwang-Hyub Han and Jinsil Seong

    Version of Record online : 29 JUL 2013, DOI: 10.1111/liv.12274

  19. Clinical parameters predictive of outcomes in sorafenib-treated patients with advanced hepatocellular carcinoma

    Liver International

    Volume 33, Issue 6, July 2013, Pages: 950–957, Ju-Yeon Cho, Yong-Han Paik, Ho Yeong Lim, Young Gon Kim, Hyo Keun Lim, Yang Won Min, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik and Byung Chul Yoo

    Version of Record online : 21 APR 2013, DOI: 10.1111/liv.12168

  20. You have free access to this content
    Poster Session 3: Cellular Immunobiology and Clinical Hepatobiliary Neoplasia

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 828A–889A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27524